CCO Slideset

Coverage of the 2006 International Congress on Drug Therapy in HIV Infection

Source: CCO Independent Conference Coverage of the 2006 International Congress on Drug Therapy in HIV Infection*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Coverage of the 2006 International Congress on Drug Therapy in HIV Infection

Faculty:

Anton L. Pozniak, MD, FRCP

CME CREDIT INFORMATION

Release Date: 01/26/07

Expiration Date: 01/25/08

Physicians: maximum of 1.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the results of recent studies of approved and investigational antiretroviral agents
Discuss recent insights into the management and prevention of metabolic complications in HIV-infected patients
Explain new findings on and management of hepatitis coinfection in HIV-infected patients

Review and download slides summarizing the most clinically relevant data on antiretroviral therapy and complications of HIV disease at the recent Glasgow meetings.

This slide presentation is in Microsoft PowerPoint format and is available for download within the CME module.

Topics covered include:

New Data on Current and Investigational Antiretroviral Agents
Metabolic Effects of HIV Infection and Antiretroviral Therapy
New Data on Drug Resistance and Drug-Drug Interactions
New Insights on Managing Hepatitis-Coinfected Patients

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.